Last reviewed · How we verify

Vaginal gel HYALOGYN®

Ospedale Policlinico San Martino · FDA-approved active Small molecule

HYALOGYN® is a hyaluronic acid-based vaginal gel that provides lubrication and hydration to restore vaginal moisture and elasticity.

HYALOGYN® is a hyaluronic acid-based vaginal gel that provides lubrication and hydration to restore vaginal moisture and elasticity. Used for Vaginal dryness and atrophic vaginitis, Vaginal lubrication and moisture restoration.

At a glance

Generic nameVaginal gel HYALOGYN®
SponsorOspedale Policlinico San Martino
Drug classVaginal moisturizer/lubricant
ModalitySmall molecule
Therapeutic areaGynecology
PhaseFDA-approved

Mechanism of action

Hyaluronic acid is a naturally occurring polysaccharide with high water-binding capacity that mimics the vaginal environment's natural hydration. The gel formulation delivers sustained moisture to vaginal tissues, alleviating symptoms of vaginal dryness and improving tissue comfort and elasticity. This mechanism addresses symptoms associated with atrophic vaginitis and vaginal dryness without hormonal activity.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: